ReviewThe oncologist2023

Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy.

Ajoy Oommen John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.